Dell Technologies is helping i2b2 tranSMART Foundation, a non-profit open-source research organization, mobilize huge amounts of global de-identified patient data to create virtual models of patients – known as digital twins – to treat impacts of long-haul COVID-19. Through Dell Technologies’ modern infrastructure, the i2b2 tranSMART community will use de-identified patient data to produce digital…
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the launch of antiviral drug Favipiravir (brand name FabiFlu) for the treatment of mild to moderate COVID-19 patients. Glenmark has received manufacturing and marketing approval from India’s drug regulator, making FabiFlu the first oral Favipiravir-approved medication in India for the treatment of COVID-19, the company said.…
Sun Pharmaceutical Industries Ltd, a Mumbai-headquartered pharmaceutical company, announced that it has received approval from the Drugs Controller General of India (DCGI) to initiate a clinical trial with Nafamostat Mesilate in Covid-19 patients. The company said that Nafamostat is approved in Japan for improvement of acute symptoms of pancreatitis and treatment of Disseminated Intravascular Coagulation…
Biocon Ltd, an innovation-led global biopharmaceuticals company, announced that its subsidiary Biocon Biologics has received the Drugs Controller General of India’s (DCGI) approval for an extracorporeal blood purification (EBP) device CytoSorb to reduce pro-inflammatory cytokines levels in confirmed COVID-19 patients admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure. The company…
Innoplexus AG announced some first results in its artificial intelligence enabled search for a COVID-19 antiviral treatment. Innoplexus began by scanning data on previously approved drugs for off-label potential in treating COVID-19, using its proprietary artificial intelligence (AI) and big data platform to generate actionable insights from hundreds of terabytes of structured and unstructured public…
Amazon Care, the medical care arm for Amazon’s employees, has recently partnered with Bill Gates-backed research program SCAN to pick up and deliver at-home coronavirus test kits in Seattle. As reported first by CNBC, Amazon is going to be working with Seattle Coronavirus Assessment Network, or SCAN, a new research initiative backed in part by…
API major, Lasa Supergenerics Ltd in collaboration with Institute of Chemical Technology (ICT) recently announced commencement for Development of antiviral Compound Favipiravir as Covid-19 Treatment. Commenting on the development, Dr Omkar Herlekar, Chairman– Lasa Supergenerics Limited, said Health and safety of our countrymen is of pristine importance and to safeguard them from deadly corona we…